Latest Posts › Coronavirus/COVID-19

Share:

Guidelines for the Return to Office - Part 1: How to Handle Masking Under New and Evolving CDC Guidance

The More Things Change . . . This is the first in a series on key issues regarding the “Return to Office”. We started planning this series earlier this summer and, like many of our clients’ plans, it got delayed and kept...more

Mandating COVID-19 Vaccinations in Independent K-12 Schools: Protecting Students’ Well-Being and Minimizing Legal Risks

On May 10, 2021, the Food and Drug Administration (FDA) approved the Pfizer-BioNTech vaccine for children ages 12-15, expanding the Emergency Use Authorization (EUA) originally issued on December 11, 2020 for individuals ages...more

Staying Vigilant: New Developments Highlight Unknowns About Vaccinations and Evolving Workplace Safety Rules

In President Biden’s March 11, 2021 speech, he urged everyone to “stay vigilant” against the virus even as more vaccines are rolled out. The same applies to employers. Three recent developments—an employee lawsuit challenging...more

The FFCRA and the New Coronavirus Relief Package

The Families First Coronavirus Response Act (FFCRA), which went into effect back in March, required covered employers (those with fewer than 500 employees, with some exceptions) to provide emergency paid sick leave and...more

Frequently Asked Questions on Workplace Vaccine Policies

On December 11, 2020, the Food and Drug Administration issued emergency use authorization (EUA) for a COVID-19 vaccine developed by Pfizer. On December 18, 2020, the FDA granted similar approval to a vaccine developed by...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide